my pals over at corcept continue to lose money you may recall corcept as the company that is trying desperately to get mifepristone ru approved to treat depression the main problem has been that trial results have yielded little hope the oft cited both on this site and in the psychiatric literature charles nemeroff has a conflict of interest related to corcept that you can read about here here 's the latest on corcept rttnews corcept therapeutics inc cort charts news powerrating reported a third quarter net loss of million or per share , compared to a net loss of million or per share in the same quarter of last year analysts polled by first call thomson financial expected the company to report a loss of per share for the nine months of , the company reported a net loss of million or per share , compared to a net loss of million or per share in the year ago period collaboration revenue for the period was thousand link here